120 related articles for article (PubMed ID: 31846476)
1. Use of detailed family history data to improve risk prediction,with application to breast cancer screening.
Jiang Y; Weinberg CR; Sandler DP; Zhao S
PLoS One; 2019; 14(12):e0226407. PubMed ID: 31846476
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.
Ahern TP; Sprague BL; Bissell MCS; Miglioretti DL; Buist DSM; Braithwaite D; Kerlikowske K
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):938-944. PubMed ID: 28096200
[No Abstract] [Full Text] [Related]
4. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
Louro J; Román M; Posso M; Vázquez I; Saladié F; Rodriguez-Arana A; Quintana MJ; Domingo L; Baré M; Marcos-Gragera R; Vernet-Tomas M; Sala M; Castells X;
PLoS One; 2021; 16(3):e0248930. PubMed ID: 33755692
[TBL] [Abstract][Full Text] [Related]
5. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
6. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer.
Mukama T; Kharazmi E; Xu X; Sundquist K; Sundquist J; Brenner H; Fallah M
JAMA Oncol; 2020 Jan; 6(1):68-74. PubMed ID: 31725845
[TBL] [Abstract][Full Text] [Related]
7. Family history and risk of breast cancer: an analysis accounting for family structure.
Brewer HR; Jones ME; Schoemaker MJ; Ashworth A; Swerdlow AJ
Breast Cancer Res Treat; 2017 Aug; 165(1):193-200. PubMed ID: 28578505
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants.
Abdel-Rahman O
Clin Breast Cancer; 2020 Aug; 20(4):300-306. PubMed ID: 32327298
[TBL] [Abstract][Full Text] [Related]
10. Population-based relative risks for specific family history constellations of breast cancer.
Albright FS; Kohlmann W; Neumayer L; Buys SS; Matsen CB; Kaphingst KA; Cannon-Albright LA
Cancer Causes Control; 2019 Jun; 30(6):581-590. PubMed ID: 31030355
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
[TBL] [Abstract][Full Text] [Related]
13. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
Berry DA; Parmigiani G; Sanchez J; Schildkraut J; Winer E
J Natl Cancer Inst; 1997 Feb; 89(3):227-38. PubMed ID: 9017003
[TBL] [Abstract][Full Text] [Related]
14. A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors.
Zheng Y; Hua X; Win AK; MacInnis RJ; Gallinger S; Marchand LL; Lindor NM; Baron JA; Hopper JL; Dowty JG; Antoniou AC; Zheng J; Jenkins MA; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):549-557. PubMed ID: 31932410
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk assessment: Evaluation of screening tools for genetics referral.
Himes DO; Zaro ML; Williams M; Freeborn D; Eggett DL; Kinney AY
J Am Assoc Nurse Pract; 2019 Oct; 31(10):562-572. PubMed ID: 31425377
[TBL] [Abstract][Full Text] [Related]
16. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
17. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
[TBL] [Abstract][Full Text] [Related]
18. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
[TBL] [Abstract][Full Text] [Related]
19. Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study.
Taghipour S; Banjevic D; Fernandes J; Miller AB; Montgomery N; Harvey BJ; Jardine AK
Breast Cancer Res Treat; 2012 Jul; 134(2):839-51. PubMed ID: 22689090
[TBL] [Abstract][Full Text] [Related]
20. Women with Family History of Breast Cancer: How Much Are They Aware of Their Risk?
Seven M; Bağcivan G; Akyuz A; Bölükbaş F
J Cancer Educ; 2018 Aug; 33(4):915-921. PubMed ID: 28474221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
